Cellvizio® by Mauna Kea Technologies

During #ColorectalCancerAwarenessMonth, take a moment to learn how #Cellvizio aids in the management of colorectal neoplasia for real-time polyp characterization and guided treatment: hubs.la/Q0483K-g0 #ScreeningSavesLives @CCAlliance

This systematic review concludes that nCLE demonstrates strong diagnostic performance in characterising pancreatic cystic lesions, with pooled sensitivity reaching 0.89 (fixed effects) and 0.88 (random effects), & specificity between 82–100%. hubs.la/Q046rLtp0 #nCLE #GI

We announce the CLIMB study has been selected for the @ASGEendoscopy Presidential Plenary Session at @DDWMeeting 2026! Led by @som_krishna, this 14-site U.S. study validates nCLE’s superior accuracy for #pancreaticcyst management. hubs.la/Q046wGnm0 $ALMKT #DDW2026

This case demonstrates integration of EUS-nCLE for real-time diagnosis & EUS-RFA for immediate therapy in a high-risk patient. Clinicians identified “flat epithelium and monolayered nuclei” consistent with low-grade dysplasia and 97% diagnostic accuracy. hubs.la/Q0464QN30

Via @springernature: probe-based confocal laser endomicroscopy (pCLE) is transforming GI care, achieving nearly 2x higher sensitivity detecting neoplasia in Barrett's esophagus vs. standard protocols. See the expanding role of pCLE (#Cellvizio): hubs.la/Q045mBN10 #GITwitter

Data from @AGA_Gastro shows GI diseases cost the U.S. health system $111B annually, with 23.5M endoscopies per year, underscoring the need for advanced tools like #Cellvizio to provide faster answers & better outcomes. hubs.la/Q043Vz7b0 #NationalCancerPreventionMonth

The data is clear: A recent review in @BMJOpen_Gastro confirms that EUS-nCLE boasts >90% accuracy for pancreatic cystic lesions by providing real-time, microscopic clarity that can prevent unnecessary, high-risk surgeries. hubs.la/Q043VcVR0 #pancreaticcysts #GITwitter

Major milestone! New regulatory approvals in Switzerland & the UK accelerate our global expansion of #Cellvizio and @CellTolerance, opening doors to two of Europe’s most strategic markets for interventional gastroenterology. hubs.ly/Q044fYJY0 $ALMKT

We had a fantastic @CellTolerance Discovery Day at Clinique Paris-Bercy! Physicians joined Dr. Maryan Cavicchi to observe live #CellTolerance powered by #Cellvizio cases on patients with real-time results confirming which patients had #foodintolerances & which didn't. #IBS

@maunakeatech was featured on @bfmbusiness! A great signal of continued interest from the investment community in our company and our innovative technology. Catch the replay here: hubs.la/Q043qcZ40 #Cellivizio #SeeCellsChangeLives #MedTech

Cellvizio® and its associated probes have received CE Mark certification under the European Medical Device Regulation (MDR), a major regulatory milestone reinforcing our commitment to the highest standards of safety and clinical performance. $ALMKT PR: hubs.la/Q042xXHq0

.@WHO states, “between 30% and 50% of #cancer deaths could be prevented by modifying or avoiding key risk factors.” Addressing this through #earlydetection is core to our mission at Mauna Kea Technologies, where we strive to transform patient mgmt & care. hubs.la/Q041kh-Z0

Organizational updates to fuel our global expansion. Following @CellTolerance's €1M sales milestone, we’re expanding in EU, Middle East & Australia and advancing our #pancreaticcyst franchise via @ESGE_news guidelines. hubs.la/Q041Tx-Y0 $ALMKT

On #WorldCancerDay, we join the global effort to raise awareness and unite against cancer. Learn how #Cellvizio can make early cancer detection a reality to improve patient outcomes and long-term prognosis. Visit: hubs.ly/Q040VRKK0 #SeeCellsChangeLives

More highlights from the @CellTolerance Workshop at Klinikum Bamberg! 3 live cases demonstrated cellular reactions to food triggers, sparking insightful discussions on advancing integrated care. How Prof. Dr. med. Langhorst uses CellTolerance: hubs.la/Q041BqXM0 #GITwitter

Inspiring day at the @CellTolerance Workshop in Bamberg! Witnessed 3 live cases showing how cells react to food triggers. True innovation in action. Thanks to Prof. Langhorst & team for the expertise! See more: hubs.la/Q041mspS0 #Gastroenterology #CellTolerance #GITwitter

Traditional #foodintolerance testing often relies on delayed markers. The @CellTolerance test provides immediate diagnostic clarity by revealing cellular-level gut reactions to food in real-time. Give #IBS patients answers & relief, faster. hubs.la/Q040vsTh0 #GITwitter

The free #Cellvizio app is easy to use, from anywhere. Enhance your image pattern recognition skills and use samples from our video library as references to compare your cases with examples from a wide range of indications. #Gastroenterology #Pulmonology #GITwitter

We announce a breakthrough Q4 driven by strong U.S. expansion & @CellTolerance growth. Highlights: +19% Q4 revenue, momentum in #pancreaticcysts, €1M FY2025 CellTolerance sales, 4 new U.S. system sales, & a partnership with @TaeWoongUSA. hubs.la/Q03_0YR_0 $ALMKT

Our strong Q4 performance is a direct reflection of the trust and collaboration we share with our customers and partners. This milestone isn't just a win for our company, but a testament to the powerful community we’ve built together. $ALMKT @maunakeatech maunakeatech.com/news/mauna-kea…